Single-nucleotide polymorphisms (SNPs) constitute the great majority of variations in the human genome, and as heritable variable landmarks they are useful markers for disease mapping and resolving population structure. Redundant coverage in overlaps of large-insert genomic clones, sequenced as part of the Human Genome Project, comprises a quarter of the genome, and it is representative in terms of base compositional and functional sequence features. We mined these regions to produce 500,000 high-confidence SNP candidates as a uniform resource for describing nucleotide diversity and its regional variation within the genome. Distributions of marker density observed at different overlap length scales under a model of recombination and population size change show that the history of the population represented by the public genome sequence is one of collapse followed by a recent phase of mild size recovery. The inferred times of collapse and recovery are Upper Paleolithic, in agreement with archaeological evidence of the initial modern human colonization of Europe.
Single-nucleotide polymorphisms (SNPs) constitute the great majority of variations in the human genome, and as heritable variable landmarks they are useful markers for disease mapping and resolving population structure. Redundant coverage in overlaps of large-insert genomic clones, sequenced as part of the Human Genome Project, comprises a quarter of the genome, and it is representative in terms of base compositional and functional sequence features. We mined these regions to produce 500,000 high-confidence SNP candidates as a uniform resource for describing nucleotide diversity and its regional variation within the genome. Distributions of marker density observed at different overlap length scales under a model of recombination and population size change show that the history of the population represented by the public genome sequence is one of collapse followed by a recent phase of mild size recovery. The inferred times of collapse and recovery are Upper Paleolithic, in agreement with archaeological evidence of the initial modern human colonization of Europe.
I
nformation on the demographic history of a species is imprinted in the distribution of sequence variations in its genome. The completion of a draft sequence for the human genome provides a useful substrate for both the detection of sequence variants and a study of their distribution. To date, the number of publicly available single-nucleotide polymorphisms (SNPs) well exceeds two million (dbSNP build 105). The main data sources for computational SNP discovery have been expressed sequence tags (ESTs) (1, 2) , genomic restriction fragments (3), sequences aligned to genome both from the ends of bacterial artificial chromosomes (BACs) and from random shotgun sequences of clone sequence, and overlapping regions of genomic clone sequences themselves (4, 5) . Generally, SNPs from these data were detected in surveys of a few chromosomes, an ascertainment strategy that biases allele frequency patterns toward common variations (6) , and thus these data are expected to fall into a range that is unlikely to contain the majority of clinically important mutations (7, 8) . Under the ''common disease, common allele'' hypothesis, however, these common variants may be of special importance. In either case, to assess the potential utility of these data for inferences of gene function or population history, one must first understand its overall structure and distribution in the genome. Statistical power in such analyses requires a large amount of data, ascertained under uniform, well-characterized conditions. Clone overlaps and their derived variations are well suited for this task, as long (up to 100 kb) regions of redundant sequence coverage distributed in roughly even intervals (5) , covering nearly a quarter of the genome. The fact that regions in a wide range of overlap length are available makes this set especially suited for studying the effects of recombination and demographic size f luctuation on the spatial (density) distribution of genomic sequence variations. To this end, we built a set of reagents (pairwise sequence alignments and their corresponding sets of variation) by analyzing the overlapping regions of large-insert clones sequenced as part of the human genome project. These data provided marker density observations grouped by overlap fragment length. Extending previous methods (9, 10), we implemented simulation and numerical techniques to estimate population genetic parameters that best describe these observed data. We report results indicating that both the effects of recombination and substantial changes in effective population size are required to fit models of neutral sequence evolution to observed marker densities.
Methods Overlap Detection, SNP Discovery, and Tabulation of Observed Marker
Density. The initial data consisted of genomic clones of either finished or draft quality that were part of the September 5, 2000, genome data freeze. Regions of known human repeats and low complexity sequence were masked with REPEATMASKER (Arian Smit, http:͞͞repeatmasker.genome.washington.edu). Candidate sequence overlaps were determined by a fast initial similarity search with MEGABLAST (11), followed by pairwise alignment with the dynamic programming algorithm CROSSMATCH (Phil Green, www.phrap.org). Draft quality sequence is often composed of unordered fragments; hence an overlap between two such clones is broken up into a set of partial overlap fragments. Overlaps were retained for further analysis if: (i) both clones resided on the same chromosome, as could be determined by physical mapping; and (ii) total overlap length was Ͼ6 kb, counting only overlap fragments longer than 3 kb in the total. Overlap fragments were analyzed with the POLYBAYES SNPdiscovery program (12) . An observed mismatch was called a candidate SNP if the corresponding POLYBAYES probability value was at least 0.80, and there were no discrepancies in the five base pairs immediately flanking either side. To avoid false positive predictions caused by the erroneous alignment of divergent copies of segmental duplications (sequence paralogy) we have excluded overlap fragments with Ͼ1 SNP per 400 nucleotides. This censorship procedure, necessary to maintain a high quality for the candidate set, also removes overlap fragments in which the inherent polymorphism rate was genuinely high. The resulting bias was estimated in subsequent analysis. An addiAbbreviations: SNPs, single-nucleotide polymorphisms; BAC, bacterial artificial chromosome.
Data deposition: SNPs discovered in this study are available from the dbSNP web site (http:͞͞ncbi.nlm.nih.gov͞SNP), under the ''KWOK'' submitter handle (accession nos. ss1566252-ss2075206).
tional bias was introduced when regions of low-quality sequences were analyzed. These regions cannot be effectively evaluated for SNPs, as sequence differences are more likely to represent sequencing errors than true polymorphisms. We rectified this bias by adjusting the overlap interval to include only the highquality portions of the overlaps [i.e., where the base quality value (13) was Ͼ35 in both sequences]. This procedure discarded Ϸ5% of the total overlap length.
Integration with the Public Genome Assembly. To ensure an unbiased evaluation of the density distributions with respect to the reference genome sequence, we included only those portions of our overlaps that were also present in the genome assembly based on the September 5, 2000, data (14) . We evaluated repeat content in the genome, as well as in the clone overlap regions by using REPEATMASKER. We used custom software to compute GϩC nucleotide and CpG dinucleotide content.
SNP Validation and Estimation of Allele Frequency.
The experimental methods and conditions used to assess the candidate SNPs were fully described previously (15) .
Modeling Marker Density Distributions. Mismatch distributions describe the likelihood of observing k (k ϭ 0, 1, 2, . . .) polymorphic sites (mismatches) when n sample sequences of a given length, L, are compared (n ϭ 2 in this study). Traditionally, the opposing effects of meiotic recombination and co-ancestry have been studied under two simple, yet extreme, scenarios (Fig. 1a) . A simple (first-order) model that ignores any structure imposed by demographic history and assumes complete independence between the genealogies of neighboring sites because of recombination (infinite recombination model) predicts a Poisson mismatch distribution driven solely by the mutation rate (16) . Conversely, a first-order model that accounts for genealogical structure only through static demographic history and ignores recombination (zero-recombination model) predicts a geometric distribution of mutational differences (17) .
A detailed demographic history described by the time evolution of effective population size, N e , profoundly affects the distribution of polymorphic sites shared between individuals. In particular, a large increase of the effective population size yields an overabundance of new lineages that increase the likelihood that random sequence pairs will harbor one or more mutational differences (9) (Fig. 1b) . Alternatively, a sharp decrease in effective population size raises the likelihood of relatedness between random pairwise DNA samples, resulting in the opposite effect: an overrepresentation of sequence identity (zero difference) as seen in Fig. 1c . Both models represent a secondorder changing population size dynamics characterized by different effective population sizes in each of two epochs: an ancestral size N 2 , followed by a size change to N 1 , happening T 1 generations ago. It is possible to go to higher-order models by increasing the number of epochs in a population history. An example third-order (three-epoch) model is the ''bottleneck'' dynamics (i.e., a collapse followed by a phase of recent population recovery) depicted in Fig. 1d .
While the density distribution can be computed explicitly for zero-recombination models even with high-order population dynamics (9) , no explicit formulas are available for models with realistic levels of recombination. In these cases, we are reliant on numerical simulations that use the coalescent process with recombination (18) . Implementing this technique with custom software, we were able to study the counterparts of the previous (zero-recombination) models with realistic levels of recombination ( Fig. 1 ). Models used a uniform genome-averaged mutation rate, ϭ 2.0 ϫ 10 (21)] when appropriate. We note that an alternative estimate of ϭ 1.0 ϫ 10
Ϫ8
, although less conventional, is perhaps more plausible, as it accounts for a larger ancestral anthropoid population size and older separation times (20, 22) . The latter rate estimate will yield a human effective size estimate of 20,000 rather than 10,000 (below), and double the time estimates for demographic events. Initial simulations were run with 100,000 replicates per parameter set, and refinements for the best-performing parameter sets were reevaluated with one million replicates.
Model Parameterization. A given model is specified by a recombination rate (r ϭ 0 or 1.0 ϫ 10
Ϫ9
) and a vector of population sizes (N i ) and epoch durations (T i ) determined by the model's order (for examples of such parameter sets see Table 1 ). Values of N i (ranging from 1,000 to 100,000) were sampled in units of 100 for numerical calculations and for one-epoch model simulations, and in units of 1,000 for higher-epoch model simulations. Values of T i (ranging from 100 to 10,000) were sampled in units of 100 for all cases. Predicted marker density distributions were generated for each length scale analyzed (L ϭ 4, 6, 8, 10, 12, 14, and 16 kb) for each parameter set considered from the multidimensional parameter space defined above.
Model Evaluation. Parameter sets within a fixed model structure were compared by computing, for each competing model, a degree of fit between the observed (o) marker density distribution and the probability distribution predicted by each of the models (m), using the log likelihood of the data given the model in question. Because observations between different overlap fragment length classes, as well as observations for each of the number of differences, k, were independent, this likelihood is described by a multinomial distribution:
where O L is the number of overlap fragments in class L, O L,k is the number of fragments with k differences, C L is the maximum number of differences permitted by the censorship procedure for length L, and m L,k is the marker density probability predicted by the model, at length class L, for k differences. In evaluating an alternative goodness of fit for a given model, we used the 2 metric (see Discussion):
Using either of the above metrics requires the model-predicted probability distributions to be calculated very accurately, especially in mismatch categories with low predicted probabilities. In those cases where the distribution can be calculated only with simulations, accuracy is constrained by the practical upper limit on the number of simulation replicates. To avoid numerical instability, we restricted fit testing to the first K L categories within each length class such that categories k ϭ 0, 1, . . . , K L contain 95% of all fragments for that class.
Model Comparison. The performances of different model structures were compared based on the maximum likelihood parameter estimates for each model structure. Standard tools of normal hypothesis testing could be used (23) when two nested models were compared, by calculating the likelihood ratio, , between the less restricted and more restricted model. The quantity 2 ln() is expected to be asymptotically 2 distributed with degrees of freedom equal to the difference in the number of parameters. Increasing the number of epochs by one adds two parameters to the model (the effective population size, and the duration of the new epoch). Considering recombination adds one extra parameter to the model structure. The less restricted 
Three-epoch N 3 ϭ 9,000 T 2 ϭ 7,000 0 N 2 ϭ 50,000 Ϫ469.64 -2 ln ϭ 180.22 (P Ͻ 1 ϫ 10 Ϫ7 ) T 1 ϭ 7,000 N 1 ϭ 9,000
N2 ϭ 5,000 Ϫ463.07 2 ln ϭ 13.14 (P Ͻ 2.89 ϫ 10 Ϫ4 ) 2l n ϭ 7.5 (P Ͻ 0.023)
For each model, we report the population parameter values within a given model structure that produced the best fit to the observations. We also report the corresponding log likelihood, ln P(data͉model). The penultimate column reports the statistical significance of model improvement attributable to the introduction of a genome average recombination rate into our models (adding one extra model parameter). The final column reports the significance of the model improvement attributable to the introduction of an additional epoch (two extra model parameters). Significance of the improvement was evaluated with statistical hypothesis testing for nested model structures (see Methods).
model
Monte Carlo Testing of Data Fit.
To analyze the behavior of our models in the face of increasing amounts of observed data we generated random subsets of the observed data set of given fractions. At each fraction, we generated 1,000 subsets. For each subset, and for a given model, we determined whether the fit between the predicted marker density distribution and the observation subset could be rejected as statistically insignificant by the described 2 test. We calculated the proportion of subsets for which the model prediction could not be rejected, and tabulated these proportions for each of the data fractions analyzed.
Results
Data Collection and Assessment. We analyzed 25,901 genomic clones consisting of 7,122 finished and 18,779 draft sequences for which PHRAP (13) base-quality scores were available. We identified 21,020 clone overlaps (Methods) comprising 124,356 overlap fragments (see Methods). The total pairwise length of these overlaps was 1,105 megabases. Using the POLYBAYES SNP discovery tool (12), we detected and submitted to dbSNP (24) 507,152 candidate SNPs (Methods). When the data were restricted to overlaps also present in the genome assembly (Methods), the number of overlaps reduced to 18,074 overlaps (average length of 51.1 Ϯ 35.5 kb) containing 399,067 candidate SNPs. Measures of GϩC, CpG, and repeat content in the overlap set were generally equivalent to average genome values, indicating it to be representative of the complete genome assembly (see Supporting Text, which is published as supporting information on the PNAS web site, www.pnas.org). To evaluate the quality of candidate SNPs, we tested for segregation in human populations and evaluated the sequence data for intrinsic error (see supporting information on the PNAS web site for details). Verification experiments show that the computational SNP predictions from the BAC overlap sequences are high quality, and the majority of SNPs are informative in one or more world populations (15) .
Estimation of Genomewide Nucleotide Diversity. By comparing the number of SNPs to the total length of pairwise overlaps analyzed, we estimated the overall value of pairwise nucleotide diversity, , for our complete dataset as 5.047 ϫ 10 Ϫ4 per nucleotide. This value, however, is biased by the inclusion of overlaps derived from the same source chromosome from a single individual. For the remainder of this study, we thus used only clone overlaps derived from interindividual libraries where both clone sequences were of draft quality. There were 3,174 such overlaps (18,152 overlap fragments, total overlap length 144 megabases). The nucleotide diversity value observed in this set ( ϭ 7.571 ϫ 10 Ϫ4 ) is in excellent agreement with the value observed for shotgun reads aligned to the human genome (25) . Our value for indicates an expectation of one SNP in every 1,321 bp of paired sequence (n ϭ 2). This average value, however, must be treated with caution, as the actual number of SNPs in an overlap of a given length is highly variable at all length scales examined (Fig. 2a) . Our value for corresponds to an effective size estimate of N e ϭ 9,464, if the mutation rate is 2.0 ϫ 10 Ϫ8 . N e should be doubled if the mutation rate is 1.0 ϫ 10 Ϫ8, putting it in line with the figure of 17,500 estimated from Alu diversity in the human genome (6).
Of Two Extreme Models, Zero Recombination vs. Full Recombination,
Zero Recombination Provides the Closest Fit to Our Data. Based on the multikilobase scale marker density distributions in the overlap data, the ''zero-recombination'' model provides a clearly superior fit (Table 1) compared with the ''infinite recombination'' model, demonstrating that the inheritance of markers in close proximity is strongly correlated, and is consistent with extensive linkage disequilibrium observed in humans (26) . This finding is an improvement over our previous study which, on the basis of marker density distribution measured in short read fragments aligned to genome sequence, did not carry sufficient power to distinguish between these competing models (25) .
Examination of Second-Order Demographic Dynamics (Two-Epoch
Model) Shows Population Collapse as the Dominant Effect. Secondorder models provided a superior fit compared with all stationary histories tested. The best-fitting parameters describe a severe, 2-to 7-fold, collapse of population size several hundred generations ago (Table 1 ). This result is consistent whether we used the zero-recombination models or a genome average recombination value. Additionally, within the class of all secondorder models tested, models with a realistic recombination value fit significantly better than those that disregarded recombination effects. 
Third-Order Models Show a Bottleneck History.
No third-order model that disregarded recombination could produce a fit superior to that of the best-fitting second-order (collapse) model with recombination (Table 1) . However, the third-order models with recombination did produce an improved fit (see Fig. 2a ) with the best-fitting parameters representing a ''bottleneck''-shaped population history. A visual representation of the best-performing parameter sets within each model class is shown in Fig. 2b . These parameter values, together with the quantitative description of the fit values are given in Table 1 . The third-order model structure with bottleneck parameters (Table 1) is our best description of the population history imprinted in the BAC overlap variation data. While all sets were qualitatively similar, the best-fitting parameter combination was slightly different for each overlap fragment length (data not shown). The overall optimum thus represents a compromise among the best-fitting parameter sets. We compared the predicted censored nucleotide diversity values predicted by the optimal model to the observed values at each length scale analyzed (Fig. 3) . The fit is better at shorter sequence length than at longer lengths, as the majority of data available at shorter lengths were weighted heavier during the determination of a global optimum.
Unbiased Estimates of Genomewide Nucleotide Diversity. The direct measurement of pairwise nucleotide diversity is confounded with the effects of the censorship procedure (Methods). Using our best-fitting model, we projected the shape of the maker density curve beyond the censorship limit, and estimated the unbiased value of pairwise nucleotide diversity intrinsic to the overlap dataset as ϭ 8.25 ϫ 10 Ϫ4 per site per generation or one substitution-like polymorphism per 1,212 nucleotides. Assuming a genome average mutation rate of ϭ 2.0 ϫ 10 Ϫ8 or 1.0 ϫ 10
Ϫ8
per site per generation, the corresponding long-term effective population size is N e ϭ 10,313 or 20,626, respectively.
Discussion
The dataset considered here, by virtue of its global nature, is expected to be robust against selection-induced distortions at individual loci and serves as a proper reagent to test theory describing the distribution of the number of mismatches in pairwise comparisons observed in a large number of different genomic regions.
Evidence from both archeological and genetic sources suggests that modern human populations are the product of an episode of explosive population growth beginning in the Pleistocene (9) . Mismatch distributions from the hypervariable regions of the human mitochondrion exhibit a wavelike shape that has been interpreted as the sign of this expansion. However, limitations on the number of loci available for population genetic analysis have restricted a more detailed demographic inference (9) . Our third-order analysis indicates that the dominant effect in our data is a collapse ca. 40,000 years ago (1,600 generations), consistent with the timing of the initial appearance of anatomically modern humans in Europe. To which population do our results refer? The ethnic composition of the DNA donors of the public human genome is not described, but genotyping of diallelelic, insertion-deletion type polymorphisms mined from the same BAC overlaps (27) suggests that the majority of these sequences represent donors of European origin. Similar patterns resulting in reduction of diversity and extension of linkage disequilibrium in European samples (26, (28) (29) (30) (31) , and reports of long invariable regions in the human genome (32) have been published. If our results indeed describe European chromosomes, then our estimated time of collapse is in good agreement with expansion time estimates from mitochondrial mismatch distributions (9) .
How do we reconcile the signature of a population collapse seen in our data with the obvious recent explosive increase in population size? The recovery visible in our data is a very modest increase of effective population size during the Upper Paleolithic (Table 1 ). This finding suggests that recent population growth is not yet deeply imprinted in the nuclear marker density distribution, presumably because of the low average nuclear mutation rate.
Although our best, three-epoch, model produces a visually convincing fit to the observed data (Fig. 2a) , application of a general 2 test reveals that the fit can be rejected at the 5% (or even at the 1%) level, and the same is true for each of the other model structures (data not shown). Does this mean that we have to discard these models as inadequate descriptions of the observed data? The models are cartoon-like, and the marker density observed in the BAC overlap data was shaped by many unconsidered effects. If our models are not perfect, it is natural Fig. 4 . Model assessment based on the amount of data required for rejection by the general 2 test. For each model, at each data fraction, we have plotted the percentage of successful trials (random data subsets for which the model cannot be rejected by the 2 test at the 5% level). r indicates models with recombination. to ask how well they perform in an ''absolute'' sense, instead of relative terms, compared with each other. In all cases, model rejection is based on statistical significance, which in turn is always defined in the context of the test data at hand. Therefore, it is possible that a model that could not be rejected on the basis of a given dataset later proves inaccurate (rejected) when additional testing data become available. This consideration provides an alternative way to evaluate model accuracy, by examining how much data are necessary for the rejection of each of the competing models. The better the model, presumably, the larger the dataset that is required for its rejection as inaccurate. Accordingly, we have performed a computational experiment to examine how a 2 measure of data fit between our observations and best-fitting models decays as more and more of the original data is considered. Results are shown in Fig. 4 . Our best-fitting model (three-epoch history with uniform recombination) can be rejected only 50% of the time when subsets containing at least 15% (Ϸ2,300 overlap fragments) of the original observed data are considered. We anticipate that evaluations of this sort will become increasingly useful in the analysis of genome-scale data (over-powered experiments) where numerical models will fail traditional significance tests when genome-sized datasets are considered.
What can we do to improve our models? We know that mutation rates are not uniform in the nuclear genome (19) . There is also evidence for recombination hotspots (33) . The existence of hotspots implies that, at least to some degree, recombination favors certain regions of the genome, a departure from the uniform distribution that we have assumed in our models. We also know that population history is far more complex than we can capture in our cartoon-like models invoking instantaneous stepwise changes of effective size. The same history may or may not be true for all chromosomal regions within the genome. There is also a large corpus of literature discussing nonneutral effects such as selective sweeps (34) . It is desirable to refine our models by considering these effects. To confirm the generality of our results it will be necessary to evaluate similar data from non-European samples, analyze other characteristic distributions of SNPs such the allele frequency spectrum, and contrast our observations to data collected in molecular systems with alternative mutational mechanisms such as diallelic insertions͞deletions, short tandem repeat polymorphisms (STRPs), and mitochondrial polymorphisms.
The amount of heterogeneity observed in the BAC overlaps should be a warning that average genome measures of nucleotide diversity should be used with caution. On the other hand, our computational experiments demonstrate that even relatively simple models of random drift are adequate to predict the range of variability in our data, suggesting that drift is an important (if not the most important) component of the resultant of forces that shape the regional distribution of human variability. It is striking, for example, that purely neutral forces can account for the fact that Ϸ10% of our 16-kb overlaps did not contain a single sequence variant (Fig. 2a) . Observations such as this will require us to rethink our expectations when evaluating variation structure and its possible significance in specific genomic loci. The mature, fully annotated human reference sequence, together with an increase in well-characterized SNP markers, should afford us a high-resolution view to provide context for interpreting regional variation data, improving existing models of population history, and resolving the selective forces of genome evolution.
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Supporting Text
Detailed Properties of Overlap Sequences. Average G+C nucleotide content in the collected set of overlaps was 40.6% (genome average 40.9%), the average fraction of CpG dinucleotides was 1.85% (genome average 1.99%), and the proportion of the data in annotated human repeats was 44.2% (genome average 46.2%). Major repeat families were represented in proportions closely resembling their genome averages (L1: 15.6% vs. 16.5%; Alu: 9.6% vs. 10.7%; MaLR: 3.6% vs. 3.6%; L2: 3.4% vs. 3.2%; MIR: 2.8% vs. 2.5%; ERV1: 2.7% vs. 2.8%; respectively). These figures suggest that clone overlap sequences are representative of the rest of the genome, hence can be used as a proxy for whole genome analysis. The portion of the genome in redundant sequence coverage of at least two clones was 616 megabases (Mb), which is 22.8% of the 2,700 Mb total length of the Genome Assembly. The majority of the data (490 Mb) was in unique genomic regions circumscribed by two overlapping clones, but in many regions (126 Mb total) three or more clones overlapped a common unique genomic region. In regions of higher redundancy we analyzed each possible clone pair separately (924 Mb of pairwise sequence surveyed), hence it was possible for the same SNP to be detected in different clone pairs. The 399,067 candidate SNPs represented 305,067 unique map locations on the Genome Assembly. The breakdown of candidate SNPs according to substitution type was: 66.9% C/T (or A/G), 17.5% G/T (or A/C), 7.5% A/T, and 8.6% C/G, and the ratio of transitions to transversions was 2:1, both in agreement with earlier reports (1, 2). Data Assessment. We performed experimental allele frequency characterization on a random subset of 774 candidates by PCR amplification and resequencing in three independent, population-specific DNA pools (3) (Asian, African, and European) independent of the clone library tissue donors. Of the candidates 644 (83.2%) were present with a minimum detectable allele frequency of 5-10% in at least one of the three pools, thus providing a minimum estimate for the fraction of truly variable sites. We estimated the intrinsic false-positive rate by analyzing X chromosome overlaps for pairs of clones derived from single male donors. By necessity, these library-specific clones represent the same copy of an X chromosome. We observed an apparent sequence diversity of 2.64 SNPs per 100 kb, the result of cloning artifacts, sequencing errors, or spurious overlaps between highly similar paralogous regions. By discounting the empirical nucleotide diversity estimate (65.1 SNPs per 100 kb, described below) by this false-positive estimate, we calculated a 4% false-positive rate for the candidate SNP set. Accordingly, we estimate that the true positive rate of candidate SNPs is between 83.2% and 96%. To determine the level of congruence between these SNPs and another major data source, The SNP Consortium (4-6) (TSC), we have counted the number of SNP sites that were reported in both datasets, and found 97,400 locations. Given that these candidate loci were found in two independent surveys, these SNPs are considered "implicitly" validated.
Estimation of Genome Wide Nucleotide Diversity. This estimate, however, includes many overlaps where both clones represent the same chromosome of a single individual. Accordingly, the nucleotide diversity for overlaps where clones were derived from libraries (http://www.ncbi.nlm.nih.gov/genome/clone/nomenclature.shtml) constructed from separate individuals was significantly higher, ¢ ¡ observed in overlaps where both clones originated from a single-individual library. In the latter case, half the time we expect that both clones represent the same copy of the chromosome with any discrepancies being cloning artifacts, sequencing errors, or SNP calling errors. This observed variation rate, therefore, represents half the actual polymorphism rate plus the false-positive rate. Assuming that the error rate is the same for the interindividual overlaps gives us a direct estimate of 4.95% for the false-positive rate, corroborating our earlier estimate.
Because of the inherent spread of overlap length, the BAC overlap data set is structured in a way that permits nucleotide diversity estimation at various length scales. The amount of interindividual, draft vs. draft data plotted as a function of overlap fragment length is shown in Fig. 5 . In Fig/ 3 we have plotted average nucleotide diversity estimates for each length interval. The observed nucleotide diversity value is slightly higher at higher overlap fragment lengths because censorship (see Methods) in regions of high marker density disproportionately penalizes shorter overlaps. Several features of sequence composition and function are known to influence local nucleotide diversity: both C+G nucleotide content and CpG dinucleotide content have been reported to correlate positively with the value of nucleotide diversity (6). While our observations in the BAC overlap data confirm these findings (data not shown), these correlations alone do not explain a significant portion of the variation in .
